JPRN-jRCT2080221156未知2 期
Double-blind, Phase2 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Confirmatory Study of Dose-Response)
Taisho Pharmaceutical co., LTD0 个研究点目标入组 275 人开始时间: 2010年7月12日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 275
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Type 2 diabetes mellitus
- •- HbA1c 6.5% to 10.0%
排除标准
- •- Insulin-dependent (Require insulin regularly)
- •- Non-type 2 diabetes mellitus
- •- Having critical heart disease, other ciruculatory disease, cerebrovascular disorder, pancreatic disease and hematologic disease
研究者
相似试验
未知
4 期
Clinical Pharmaclogical study of TS-071 in Patient With Type 2 Diabetetes Mellitus(Evaluation of glycemic variability using continuous glucose monitoring)Type 2 Diabetes MellitusJPRN-jRCT1080222497Taisho Pharmaceutical co., LTD40
未知
1 期
Phase 1 Clinical Study of TS-071 in Healthy Adult Male Subjects (Single-Dose Administration)Healthy Japanese male subjectsJPRN-jRCT2080222304Taisho Pharmaceutical co., LTD57
未知
2 期
Phase II clinical study of TY-0201 in patients with chronic heart failureChronic heart failureJPRN-jRCT2080222593TOA EIYO LTD.40
未知
3 期
Phase3 Study of TS-071 in Patients With Type 2 Diabetes Mellitus (Double-blind, Parallel Group,Placebo-Controlled Study)Type 2 Diabetes MellitusJPRN-jRCT2080221620Taisho Pharmaceutical co., LTD132
已完成
2 期
Phase II Study of TS-1 with Patient-Reported Outcome(PRO) Evaluation in Elderly Patients with Advanced NSCLCon-small cell lung cancerJPRN-UMIN000002035Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School40